Roundtable Discussion: Aligning Target Validation Strategies with Investor Requirements to Secure Early Funding for Sustaining Proximity-Based Drug Discovery Programs
Time: 3:00 pm
day: Day Two
Details:
- How to position early stage induced proximity programs for successful funding rounds from Venture capital, strategic pharma partnerships and government grants?
- What data do investors want to see at different funding stages, from seed to IPO, to set up for future success?
- How can induced proximity focused biotechs differentiate themselves in an increasingly competitive drug discovery landscape to secure investment?